Scholar Rock Holding (SRRK) Current Assets (2017 - 2026)
Scholar Rock Holding (SRRK) posted quarterly Current Assets of $515.3 million for Q1 2026, up 33.75% year-over-year from $385.2 million in Q1 2025, and up 33.79% quarter-over-quarter from $385.1 million in Q4 2025.
Scholar Rock Holding (SRRK) Current Assets (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Current Assets history runs 10 years deep, the most recent figure standing at $515.3 million for Q1 2026.
- In Q1 2026, Current Assets rose 33.75% year-over-year to $515.3 million; the TTM figure through Mar 2026 stood at $515.3 million (up 33.75% YoY), while the FY2025 annual figure was $385.1 million, down 14.63% from the prior year.
- Current Assets for Q1 2026 stood at $515.3 million, up from $385.1 million in the prior quarter.
- The five-year high for Current Assets was $515.3 million in Q1 2026, with the low at $152.9 million in Q3 2024.
- The 5-year median for Current Assets is $319.1 million (2025), against an average of $318.4 million.
- The sharpest annual moves came in 2023 and 2025: Current Assets plunged 36.11% in 2023, then jumped 155.49% in 2025.
- Scholar Rock Holding's Current Assets stood at $328.0 million in 2022, then slipped by 12.14% to $288.2 million in 2023, then soared by 56.55% to $451.2 million in 2024, then slipped by 14.63% to $385.1 million in 2025, then soared by 33.79% to $515.3 million in 2026.
- Business Quant data shows SRRK's Current Assets at $515.3 million in Q1 2026, $385.1 million in Q4 2025, and $390.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Scholar Rock Holding | 6.39 Bn | 6.39 Bn | - | 507.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 507.18 Mn |
| Mar 31, 2026 | 515.28 Mn |
| Dec 31, 2025 | 385.15 Mn |
| Sep 30, 2025 | 390.71 Mn |
| Jun 30, 2025 | 319.13 Mn |
| Mar 31, 2025 | 385.25 Mn |
| Dec 31, 2024 | 451.17 Mn |
| Sep 30, 2024 | 152.93 Mn |
| Jun 30, 2024 | 199.14 Mn |
| Mar 31, 2024 | 246.93 Mn |
| Dec 31, 2023 | 288.19 Mn |
| Sep 30, 2023 | 228.47 Mn |
| Jun 30, 2023 | 259.81 Mn |
| Mar 31, 2023 | 287.16 Mn |
| Dec 31, 2022 | 328.02 Mn |
| Sep 30, 2022 | 357.61 Mn |
| Jun 30, 2022 | 389.14 Mn |
| Mar 31, 2022 | 228.59 Mn |
| Dec 31, 2021 | 265.32 Mn |
| Sep 30, 2021 | 258.16 Mn |